DK1809125T3 - Næringsmiddel, der indeholder en fedtblanding - Google Patents

Næringsmiddel, der indeholder en fedtblanding

Info

Publication number
DK1809125T3
DK1809125T3 DK05813382.8T DK05813382T DK1809125T3 DK 1809125 T3 DK1809125 T3 DK 1809125T3 DK 05813382 T DK05813382 T DK 05813382T DK 1809125 T3 DK1809125 T3 DK 1809125T3
Authority
DK
Denmark
Prior art keywords
lipid
total weight
acid
dpan
dha
Prior art date
Application number
DK05813382.8T
Other languages
English (en)
Inventor
Bernd Stahl
Guenther Boehm
Christopher Beermann
Johan Garssen
Original Assignee
Nutricia Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34927339&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1809125(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nutricia Nv filed Critical Nutricia Nv
Application granted granted Critical
Publication of DK1809125T3 publication Critical patent/DK1809125T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/22—Comminuted fibrous parts of plants, e.g. bagasse or pulp
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
DK05813382.8T 2004-11-11 2005-11-11 Næringsmiddel, der indeholder en fedtblanding DK1809125T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04026825A EP1656839A1 (en) 2004-11-11 2004-11-11 Nutrition containing lipid blend
PCT/EP2005/012122 WO2006050975A1 (en) 2004-11-11 2005-11-11 Nutrition containing fat blend

Publications (1)

Publication Number Publication Date
DK1809125T3 true DK1809125T3 (da) 2010-06-07

Family

ID=34927339

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05813382.8T DK1809125T3 (da) 2004-11-11 2005-11-11 Næringsmiddel, der indeholder en fedtblanding

Country Status (18)

Country Link
US (2) US8053471B2 (da)
EP (3) EP1656839A1 (da)
JP (1) JP2008519796A (da)
CN (2) CN102511818B (da)
AT (1) ATE457656T1 (da)
AU (1) AU2005303903B2 (da)
BR (1) BRPI0517479B1 (da)
CA (1) CA2586946C (da)
DE (1) DE602005019452D1 (da)
DK (1) DK1809125T3 (da)
ES (1) ES2341355T3 (da)
NZ (1) NZ554629A (da)
PL (1) PL1809125T3 (da)
PT (1) PT1809125E (da)
RU (1) RU2402927C2 (da)
SG (1) SG143274A1 (da)
UA (1) UA89207C2 (da)
WO (1) WO2006050975A1 (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1656839A1 (en) 2004-11-11 2006-05-17 N.V. Nutricia Nutrition containing lipid blend
BRPI0613274A2 (pt) 2005-05-23 2009-08-04 Massachusetts Inst Technology composições que contêm pufa e métodos de uso das mesmas
WO2007058523A1 (en) * 2005-11-17 2007-05-24 N.V. Nutricia Composition with docosapentaenoic acid
WO2008054192A1 (en) * 2006-11-02 2008-05-08 N.V. Nutricia Use of nutritional compositions for preventing disorders
AU2006327995B2 (en) * 2005-12-23 2012-09-13 N.V. Nutricia Infant nutritional compositions for preventing obesity
WO2008054193A1 (en) * 2006-11-02 2008-05-08 N.V. Nutricia Nutritional products that comprise saccharide oligomers
WO2009002146A1 (en) * 2007-06-26 2008-12-31 N.V. Nutricia Supporting activities of daily living
WO2009002145A1 (en) 2007-06-26 2008-12-31 N.V. Nutricia Lipid composition for improving function of brain functioning
WO2009002148A1 (en) * 2007-06-27 2008-12-31 N.V. Nutricia Food composition for prodromal dementia patients
NZ599748A (en) 2007-06-26 2013-11-29 Nutricia Nv Improving memory in subjects with mini-mental state examination of 24-26
CN100542411C (zh) * 2007-09-24 2009-09-23 张国浩 一种含ω-3多不饱和脂肪酸的营养均衡调和油及其生产方法
CN101951923B (zh) 2007-12-20 2013-10-30 N.V.努特里奇亚 含核苷酸/核苷的液态产品
US20090264520A1 (en) * 2008-04-21 2009-10-22 Asha Lipid Sciences, Inc. Lipid-containing compositions and methods of use thereof
US9149452B2 (en) * 2009-04-20 2015-10-06 Women's & Children's Health Research Institute Inc. Methods and compositions for promoting the neurological development of an infant
JP5335601B2 (ja) * 2009-07-30 2013-11-06 ビーンスターク・スノー株式会社 栄養組成物
WO2012087113A1 (en) * 2010-12-24 2012-06-28 N.V. Nutricia Improved nutritional tablet
BR112014016135A8 (pt) * 2011-12-27 2017-07-04 Abbott Lab uso de uma fórmula para lactentes com caloria reduzida contendo nucleotídeos e/ou carotenóides para reduzir os efeitos adversos à saúde em uma idade mais avançada
WO2013192109A1 (en) 2012-06-17 2013-12-27 Matinas Biopharma, Inc. Omega-3 pentaenoic acid compositions and methods of use
CA2905671A1 (en) * 2013-03-13 2014-09-18 Matinas Biopharma Inc. Omega-3 pentaenoic acid compositions and methods of use
US8728546B1 (en) 2013-03-15 2014-05-20 Swing Aerobics Licensing, Inc. Medicament for treatment of cancer, cardiovascular diseases and inflammation
FR3045069B1 (fr) 2015-12-14 2019-01-25 Metabolium Procede d'enrichissement de protistes en lipides riches en acides gras polyinsatures, plus particulierement de classe omega 3, et sa mise en oeuvre pour la production de ces lipides
CA3073946A1 (en) * 2017-08-25 2019-02-28 Struct Nutrition, Llc Compositions and methods for preventing, alleviating, and treating neurological injury following head trauma
WO2023232882A1 (en) 2022-05-31 2023-12-07 N.V. Nutricia Infant formula for improving cognitive development

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4670285A (en) * 1982-08-06 1987-06-02 The University Of Toronto Innovations Foundation Infant formula
ES2033193B1 (es) * 1990-10-30 1994-01-16 Ganadera Union Ind Agro Mezcla grasa para nutricion infantil y de adultos.
KR940003473A (ko) 1992-08-14 1994-03-12 이순목 n-3 지방산이 축적된 우유 및 우유용 사료조성물
NL9401644A (nl) * 1994-10-06 1996-05-01 Friesland Brands Bv Voedingsmiddel voor zwangere en lacterende vrouwen
US6582941B1 (en) * 1995-04-17 2003-06-24 Japan As Represented By Director-General Of Agency Of Industrial Science And Technology Microorganisms capable of producing highly unsaturated fatty acids and process for producing highly unsaturated fatty acids by using the microorganisms
ES2244970T3 (es) * 1995-05-30 2005-12-16 Suntory Ltd Huevos de ave domestica con alto contenido de acidos grasos altamente insaturados, procedimiento para su produccion, y uso uso.
DE69622722T2 (de) * 1996-11-20 2003-02-27 Nutricia Nv Fette enthaltende Ernährungszusammensetzung zur Behandlung des Stoffwechselsyndroms
SK112399A3 (en) * 1997-02-21 2000-12-11 Abbott Lab Methods and compositions for reducing the incidence of necrotizing enterocolitis
AU745551B2 (en) * 1997-03-27 2002-03-21 Bristol-Myers Squibb Company Use of docosahexanoic acid and arachidonic acid enhancing the growth of preterm infants
US6432684B1 (en) * 1997-04-11 2002-08-13 Abbott Laboratories Human desaturase gene and uses thereof
AU6503699A (en) * 1998-10-05 2000-04-26 Abbott Laboratories Altered fatty acid biosynthesis in insect cells using delta five desaturase
US6596302B2 (en) * 2000-04-13 2003-07-22 Abbott Laboratories Infant formulas containing long-chain polyunsaturated fatty acids and uses thereof
ITBO20000471A1 (it) 2000-07-31 2002-01-31 Vieri Ridolfi Dispositivo di supporto per prodotti da fumo particolarmente sigarette .
DE10057976B4 (de) 2000-11-22 2005-02-03 Südzucker AG Mannheim/Ochsenfurt Verfahren zur Herstellung von Pektinhydrolyseprodukten
US20050129739A1 (en) * 2001-05-14 2005-06-16 Gerhard Kohn Production and use of a polar lipid-rich fraction containing omega-3 and/or omega-6 highly unsaturated fatty acids from microbes, genetically modified plant seeds and marine organisms
US20040209953A1 (en) * 2002-12-06 2004-10-21 Wai Lee Theresa Siu-Ling Glyceride compositions and methods of making and using same
GB0308104D0 (en) * 2003-04-08 2003-05-14 Novartis Nutrition Ag Organic compounds
EP1656839A1 (en) 2004-11-11 2006-05-17 N.V. Nutricia Nutrition containing lipid blend

Also Published As

Publication number Publication date
US8053471B2 (en) 2011-11-08
ATE457656T1 (de) 2010-03-15
AU2005303903A1 (en) 2006-05-18
JP2008519796A (ja) 2008-06-12
BRPI0517479A (pt) 2008-10-07
CA2586946A1 (en) 2006-05-18
PL1809125T3 (pl) 2010-07-30
AU2005303903B2 (en) 2012-05-31
EP2191733A1 (en) 2010-06-02
US8729123B2 (en) 2014-05-20
EP1656839A1 (en) 2006-05-17
BRPI0517479B1 (pt) 2015-06-09
EP1809125A1 (en) 2007-07-25
CN101052316B (zh) 2012-02-22
WO2006050975A1 (en) 2006-05-18
PT1809125E (pt) 2010-05-20
US20120027885A1 (en) 2012-02-02
ES2341355T3 (es) 2010-06-18
RU2402927C2 (ru) 2010-11-10
NZ554629A (en) 2010-09-30
DE602005019452D1 (de) 2010-04-01
SG143274A1 (en) 2008-06-27
RU2007121665A (ru) 2008-12-20
CN102511818A (zh) 2012-06-27
CN101052316A (zh) 2007-10-10
CN102511818B (zh) 2014-12-24
EP1809125B1 (en) 2010-02-17
UA89207C2 (ru) 2010-01-11
CA2586946C (en) 2014-09-30
US20080269330A1 (en) 2008-10-30

Similar Documents

Publication Publication Date Title
DK1809125T3 (da) Næringsmiddel, der indeholder en fedtblanding
Brenna et al. α-Linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans
JP2008519796A5 (da)
JP2006501840A5 (da)
PL1781307T3 (pl) Immunostymulująca odżywka dla niemowląt
TW200744463A (en) Nutritional supplement containing long-chain polyunsaturated fatty acids
NO942365L (no) Lipidisk sammensetning for anvendelse som et næringsmiddel eller i næringsmiddelprodukter
EP0298293A3 (en) Fat emulsion, process for its manufacture and its use
DK1121115T3 (da) PUFA-tilskud
DK1155620T3 (da) Kosttilskudsmiddel med vitaminer, mineraler og flerumættede fedtsyrer
RU2013146517A (ru) Композиции и способы, пригодные для облегчения возрастных заболеваний
RU2008117138A (ru) Способы и композиции для улучшения когнитивной функции
CO5550401A2 (es) Mezclas lipidas y productos alimenticios que contienen acido graso oleico y acidos grasos omega-6 diseñados para aumentar el nivel de lipido intramiocelular
DK1027831T3 (da) Stabiliseret fedtstofsammensætning, fremgangsmåde til fremstilling deraf og ernæringsprodukt indeholdende denne
Gillingham The metabolic fate of alpha linolenic acid (ALA)
Hassam The influence of α-linolenic acid (18: 3ω3) on the metabolism of γ-linolenic acid (18: 3ω6) in the rat
OGUNLEIYE et al. Effect of fish oil and safflower oil in common Japanese diet on human plasma fatty acid composition
Idris et al. Effects of Chemically Interesterified Palm Olein on Lipid Profiles in Hamsters.
Burns The power of 0-3's.
Park SoYoung et al. Impact of Korean pine nut oil on weight gain and immune responses in high-fat diet-induced obese mice.
Brenna et al. ISSFAL Official Statement Number 5 α–Linolenic Acid Supplementation and Conversion to n-3 Long Chain Polyunsaturated Fatty Acids in Humans
Taugbol Studies on omega-3 polyunsaturated fatty acids as a supplement to pig nutrition.
Magazine The metabolic fate of alpha linolenic acid (ALA)
Suzuki et al. Effect of lard, palm and rapeseed oils life conservation in aged mice